Video

Dr Danish on the Use of Novel Radiotherapy Approaches in Cancer Care

Adnan F. Danish, MD, discusses the use of novel radiotherapy approaches in cancer care.

Adnan F. Danish, MD, radiation oncologist at John Theurer Cancer Center, Hackensack University Medical Center, chief, the Division of Radiation Oncology, St Joseph’s Health, discusses the use of novel radiotherapy approaches in cancer care.

Despite the benefits to treatment seen with radiotherapy, challenges still remain within this treatment modality, Danish begins. For example, imaging can detail the exact location of a tumor at a specific point in time; however, tumors can shift due to movement and changes in anatomy, Danish says. Therefore, margins of error are added to radiotherapy to accommodate for any shifts in the tumor. Over time, changes have been made to better address this issue, and pinpointing real-time locations of tumors is now easier, Danish explains. In turn, this has led to a decrease in margin of treatment, reducing adverse effects that may occur as a result of stray radiation, Danish adds. Up until this point in time, beacons or fiducials implanted in tumors have helped provide real-time location for tumors and confirm the deliver of radiation therapy, Danish expands.

However, there is now the ability to use the tumor itself as a beacon to guide radiation therapy, Danish notes. SCINTIX radiation technology is designed to deliver precise, multimodal therapy to metastatic disease sites in patients with advanced lung and bone cancers, Danish explains. Rather than assuming that the tumor is stationary and adding a margin to accommodate for changes in anatomy motion, this technology detects motion and changes in anatomy to guide radiation treatment, Danish continues. Therefore, patients can be treated with a much smaller margin with an increased therapeutic ratio of treatment, Danish concludes.

Related Videos
James J. Harding, MD, associate attending physician, Memorial Sloan Kettering Cancer Center
J. Bradley Elder, MD
Rimas V. Lukas, MD
Adam E. Singer, MD, PhD, Health Sciences Clinical Instructor, medicine, division lead, kidney cancer, Division of Hematology/Oncology, UCLA Health
Diane Reidy-Lagunes, MD, vice chair, Oncology Operations, Regional Care Network, Memorial Sloan Kettering Cancer Center
Shubham Pant, MD, MBBS
Kevin Kalinsky, MD, MS, professor, Department of Hematology and Medical Oncology, director, Division of Medical Oncology, Department of Hematology and Medical Oncology, Emory University School of Medicine; Louisa and Rand Glenn Family Chair in Breast Cancer Research, director, Glenn Family Breast Center, director, Breast Medical Oncology, Winship Cancer Institute of Emory University
Brett L. Ecker, MD
Benjamin Garmezy, MD, assistant director, Genitourinary Research, Sarah Cannon Research Institute
Yelena Y. Janjigian, MD, chief, Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center